Oxford Asset Management’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Oxford Asset Management’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-144,034	Closed	-$170K	–	1696
2019 Q4	$170K	Sell	144,034 -65,273	-31%	-$104K	﹤0.01%	1573
2019 Q3	$360K	Buy	209,307 +132,283	+172%	+$403K	0.01%	1400
2019 Q2	$365K	Sell	77,024 -7,986	-9%	-$44.7K	0.01%	1395
2019 Q1	$549K	Buy	+85,010	New	+$445K	0.01%	1178

Other funds holding NTGN

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oxford Asset Management's NTGN Position: Q1 2020 in Review

Oxford Asset Management sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q1 2020, closing a stake of 144,034 shares — an estimated $170K sold.

Oxford Asset Management first reported a position in NTGN in Q1 2019 and held it in 4 quarters. The position peaked at $549K in Q1 2019. 43 funds tracked by Wall St. Rank hold NTGN as of Q1 2020.

Oxford Asset Management reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 144,034 Neon Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $170K.
Oxford Asset Management first reported a position in Neon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
Oxford Asset Management's Neon Therapeutics, Inc. Common Stock position peaked at $549K in Q1 2019.
43 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.